AN2 Therapeutics, Inc. - Common Stock and Warrants (ANTX)

44 filings reported holding ANTX - AN2 Therapeutics, Inc. - Common Stock and Warrants as of Q2 2025.
AN2 Therapeutics, Inc. - Common Stock and Warrants (ANTX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 8.28M shares of 27.5M outstanding shares and own 30.16% of the company stock.
Largest 10 shareholders include Almitas Capital LLC (1.43M shares), VANGUARD GROUP INC (1.04M shares), Pfizer Inc (715K shares), Peapod Lane Capital LLC (583K shares), Stonepine Capital Management, LLC (544K shares), LANDSCAPE CAPITAL MANAGEMENT, L.L.C. (495K shares), BANK OF NOVA SCOTIA (459K shares), BANK OF MONTREAL /CAN/ (422K shares), RENAISSANCE TECHNOLOGIES LLC (399K shares), and BANK OF AMERICA CORP /DE/ (386K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.